Page last updated: 2024-10-22

theophylline and Hyperuricemia

theophylline has been researched along with Hyperuricemia in 2 studies

Hyperuricemia: Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT.

Research Excerpts

ExcerptRelevanceReference
"Theophylline is a useful drug for the treatment of asthma."7.73A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD. ( Adachi, M; Fukuda, T; Kihara, N; Makino, S; Miyamoto, T; Nakajima, S; Nishima, S; Ohta, K, 2006)
"Theophylline is a useful drug for the treatment of asthma."3.73A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD. ( Adachi, M; Fukuda, T; Kihara, N; Makino, S; Miyamoto, T; Nakajima, S; Nishima, S; Ohta, K, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamada, T1
Hisatome, I1
Shigemasa, C1
Makino, S1
Adachi, M1
Ohta, K1
Kihara, N1
Nakajima, S1
Nishima, S1
Fukuda, T1
Miyamoto, T1

Reviews

1 review available for theophylline and Hyperuricemia

ArticleYear
[Drug-induced hyperuricemia].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 1

    Topics: Antitubercular Agents; Diuretics; Gout; Humans; Hyperuricemia; Hypolipidemic Agents; Immunosuppressi

2003

Other Studies

1 other study available for theophylline and Hyperuricemia

ArticleYear
A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD.
    Allergology international : official journal of the Japanese Society of Allergology, 2006, Volume: 55, Issue:4

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Anti-Asthmatic Agents; Asthma; Bronchiti

2006